1. Home
  2. NPKI vs ESPR Comparison

NPKI vs ESPR Comparison

Compare NPKI & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NPK International Inc.

NPKI

NPK International Inc.

HOLD

Current Price

$12.20

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.95

Market Cap

898.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPKI
ESPR
Founded
1932
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
898.5M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
NPKI
ESPR
Price
$12.20
$3.95
Analyst Decision
Strong Buy
Buy
Analyst Count
3
6
Target Price
$14.17
$6.67
AVG Volume (30 Days)
693.6K
6.5M
Earning Date
10-30-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.38
N/A
Revenue
$259,372,000.00
$303,802,000.00
Revenue This Year
$26.96
$25.45
Revenue Next Year
$13.16
N/A
P/E Ratio
$32.40
N/A
Revenue Growth
25.65
2.83
52 Week Low
$4.76
$0.69
52 Week High
$14.00
$4.13

Technical Indicators

Market Signals
Indicator
NPKI
ESPR
Relative Strength Index (RSI) 44.82 59.47
Support Level $12.21 $3.63
Resistance Level $12.57 $4.13
Average True Range (ATR) 0.35 0.20
MACD -0.08 -0.02
Stochastic Oscillator 13.22 64.00

Price Performance

Historical Comparison
NPKI
ESPR

About NPKI NPK International Inc.

NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: